Catalyst Pharmaceuticals
+$0.23 (+4.33%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CPRX and other ETFs, options, and stocks.
About CPRX
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E.
CEO
Patrick J. McEnany
Employees
74
Headquarters
Coral Gables, Florida
Founded
2002
CPRX Key Statistics
Market cap
571.27M
Price-Earnings ratio
13.66
Dividend yield
—
Average volume
1.06M
High today
$5.56
Low today
$5.24
Open price
$5.32
Volume
1.09M
52 Week high
$7.58
52 Week low
$3.27
CPRX Earnings
$0.00
$0.04
$0.09
$0.13
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 14, After Hours